SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.

J Cyst Fibros

Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada; Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address:

Published: March 2024

Background: Short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is an innate defence protein that acts as an anti-microbial agent and regulates airway surface liquid volume through inhibition of the epithelial sodium channel (ENaC). SPLUNC1 levels were found to be reduced in airway secretions of adults with cystic fibrosis (CF). The potential of SPLUNC1 as a biomarker in children with CF is unknown.

Methods: We quantified SPLUNC1, interleukin-8 (IL-8) and neutrophil elastase (NE) in sputum of CF children treated with either intravenous antibiotics or oral antibiotics for a pulmonary exacerbation (PEx)s, and in participants of a prospective cohort of CF children with preserved lung function on spirometry, followed over a period of two years.

Results: Sputum SPLUNC1 levels were significantly lower before compared to after intravenous and oral antibiotic therapy for PEx. In the longitudinal cohort, SPLUNC1 levels were found to be decreased at PEx visits compared to both previous and subsequent stable visits. Higher SPLUNC1 levels at stable visits were associated with longer PEx-free time (hazard ratio 0.85, p = 0.04). SPLUNC1 at PEx visits did not correlate with IL-8 or NE levels in sputum or forced expiratory volume in one second (FEV) but did correlate with the lung clearance index (LCI) (r=-0.53, p < 0.001).

Conclusion: SPLUNC1 demonstrates promising clinometric properties as a biomarker of PEx in children with CF.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2024.02.009DOI Listing

Publication Analysis

Top Keywords

splunc1 levels
16
splunc1
10
splunc1 biomarker
8
cystic fibrosis
8
pex visits
8
stable visits
8
children
5
levels
5
biomarker pulmonary
4
pulmonary exacerbations
4

Similar Publications

ELD607 specifically traffics Orai1 to the lysosome leading to inhibition of store operated calcium entry.

Cell Calcium

November 2024

Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS 66103, USA. Electronic address:

Orai1 is a plasma membrane Ca channel involved in store operated calcium entry (SOCE). SOCE can regulate cell growth, exocytosis, gene expression and inflammation. We previously found that short palate lung and nasal epithelial clone 1's (SPLUNC1) sixth α-helix (α6) bound Orai1 to inhibit SOCE.

View Article and Find Full Text PDF

SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.

J Cyst Fibros

March 2024

Division of Respiratory Medicine, Department of Paediatrics, The Hospital for Sick Children, Toronto, Canada; Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. Electronic address:

Background: Short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is an innate defence protein that acts as an anti-microbial agent and regulates airway surface liquid volume through inhibition of the epithelial sodium channel (ENaC). SPLUNC1 levels were found to be reduced in airway secretions of adults with cystic fibrosis (CF). The potential of SPLUNC1 as a biomarker in children with CF is unknown.

View Article and Find Full Text PDF

SPLUNC1 regulates LPS-induced progression of nasopharyngeal carcinoma and proliferation of myeloid-derived suppressor cells.

Med Oncol

September 2022

Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.

Nasopharyngeal carcinoma (NPC) is one of the aggressive malignant tumors with high mortality, and the proliferation of myeloid-derived suppressor cells (MDSCs) could promote the metastasis of NPC through inhibiting the function of T cells. Meanwhile, SPLUNC1 was known to inhibit the malignant behavior of NPC cells, while the detailed function of SPLUNC1 in LPS-modified immune microenvironment of NPC remains unclear. To assess the impact of SPLUNC1 in immune microenvironment during the progression of NPC, NPC cells were exposed to LPS and then co-cultured with MDSCs for 48 h.

View Article and Find Full Text PDF

Asthma and its heterogeneity change with age. Increased airspace neutrophil numbers contribute to severe steroid-resistant asthma exacerbation in the elderly, which correlates with the changes seen in adults with asthma. However, whether that resembles the same disease mechanism and pathophysiology in aged and adults is poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Orai1 is a calcium channel that plays a key role in regulating inflammation and store-operated calcium entry (SOCE), whereas SPLUNC1 is a gene modifier related to asthma that inhibits Orai1's function.
  • In asthma models, researchers found that inhaling α6 peptidomimetics, derived from SPLUNC1, could lower Orai1 levels and reduce immune cell responses linked to inflammation.
  • The study revealed that α6 effectively decreased eosinophil and neutrophil counts in mice exposed to allergens, suggesting it could be a promising new treatment for asthma.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!